S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

PTC Therapeutics (PTCT) News Today

$25.16
-0.13 (-0.51%)
(As of 04/17/2024 ET)
SourceHeadline
MarketBeat logoPTC Therapeutics (NASDAQ:PTCT) Stock Rating Reaffirmed by Cantor Fitzgerald
americanbankingnews.com - April 14 at 1:26 AM
finance.yahoo.com logoPTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
finance.yahoo.com - April 11 at 10:17 AM
prnewswire.com logoPTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
prnewswire.com - April 11 at 8:00 AM
MarketBeat logoInsider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) EVP Sells $14,922.62 in Stock
americanbankingnews.com - April 7 at 6:06 AM
insidertrades.com logoPTC Therapeutics, Inc. (NASDAQ:PTCT) EVP Sells $14,922.62 in Stock
insidertrades.com - April 5 at 7:46 AM
msn.com logoSolid Biosciences gets FDA rare pediatric disease status for DMD therapy
msn.com - April 1 at 10:30 AM
marketbeat.com logoVanguard Group Inc. Boosts Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT)
marketbeat.com - April 1 at 4:12 AM
marketbeat.com logoPTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Bought by Assenagon Asset Management S.A.
marketbeat.com - March 31 at 4:42 AM
marketbeat.com logoPTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Recommendation of "Reduce" by Brokerages
marketbeat.com - March 29 at 4:26 AM
finance.yahoo.com logoPTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
finance.yahoo.com - March 28 at 9:46 AM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $35.00 at Jefferies Financial Group
marketbeat.com - March 21 at 8:36 AM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Shares Down 3.7%
marketbeat.com - March 20 at 6:48 PM
markets.businessinsider.com logoBuy Rating for PTC Therapeutics Bolstered by Positive Regulatory Prospects and Gene Therapy Advances
markets.businessinsider.com - March 19 at 7:35 PM
markets.businessinsider.com logoPTC Therapeutics Gains After Announcement Of Key Regulatory Updates
markets.businessinsider.com - March 19 at 2:35 PM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Trading Up 3.3%
marketbeat.com - March 19 at 11:58 AM
finanznachrichten.de logoPTC Therapeutics, Inc.: PTC Therapeutics Provides Key Regulatory Updates
finanznachrichten.de - March 19 at 9:34 AM
markets.businessinsider.com logoPTC Therapeutics Submits BLA To FDA For Upstaza - Quick Facts
markets.businessinsider.com - March 19 at 9:34 AM
finance.yahoo.com logoPTC Therapeutics Provides Key Regulatory Updates
finance.yahoo.com - March 19 at 9:34 AM
marketbeat.com logoWalleye Capital LLC Has $1.61 Million Stock Position in PTC Therapeutics, Inc. (NASDAQ:PTCT)
marketbeat.com - March 19 at 4:21 AM
marketbeat.com logoPTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Bought by Citigroup Inc.
marketbeat.com - March 16 at 5:44 AM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Trading Down 5.9%
marketbeat.com - March 14 at 12:47 PM
marketbeat.com logoJacobs Levy Equity Management Inc. Buys 104,024 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)
marketbeat.com - March 12 at 8:38 AM
marketbeat.com logoAdage Capital Partners GP L.L.C. Has $3.36 Million Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT)
marketbeat.com - March 11 at 6:42 AM
marketbeat.com logoQ2 2024 EPS Estimates for PTC Therapeutics, Inc. Decreased by Analyst (NASDAQ:PTCT)
marketbeat.com - March 8 at 6:50 AM
marketbeat.com logoSeven Eight Capital LP Purchases Shares of 64,722 PTC Therapeutics, Inc. (NASDAQ:PTCT)
marketbeat.com - March 7 at 8:39 AM
marketbeat.com logoFY2024 EPS Estimates for PTC Therapeutics, Inc. Lowered by Cantor Fitzgerald (NASDAQ:PTCT)
marketbeat.com - March 7 at 7:23 AM
markets.businessinsider.com logoPTC Therapeutics: Navigating Challenges and Pursuing Growth Amidst Regulatory Hurdles
markets.businessinsider.com - March 7 at 7:10 AM
markets.businessinsider.com logoBuy Rating Affirmed for PTC Therapeutics Amid Promising Regulatory Progress and Market Opportunity
markets.businessinsider.com - March 6 at 5:40 PM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Shares Gap Down on Analyst Downgrade
marketbeat.com - March 3 at 1:03 AM
finance.yahoo.com logoPTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 2 at 10:28 AM
finance.yahoo.com logoPTC Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - March 2 at 10:28 AM
marketbeat.com logoCantor Fitzgerald Reiterates "Overweight" Rating for PTC Therapeutics (NASDAQ:PTCT)
marketbeat.com - March 1 at 10:49 AM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Price Target Increased to $28.00 by Analysts at Royal Bank of Canada
marketbeat.com - March 1 at 10:42 AM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Shares Gap Down After Analyst Downgrade
marketbeat.com - March 1 at 10:15 AM
marketbeat.com logoPTC Therapeutics (NASDAQ:PTCT) Price Target Lowered to $30.00 at TD Cowen
marketbeat.com - March 1 at 9:16 AM
markets.businessinsider.com logoPTC Therapeutics: Hold Rating Amidst Revenue Downturn and Regulatory Hurdles
markets.businessinsider.com - March 1 at 2:08 AM
finance.yahoo.com logoPTC Therapeutics Inc (PTCT) Reports Robust Revenue Growth and Advances in Pipeline
finance.yahoo.com - February 29 at 9:07 PM
prnewswire.com logoPTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
prnewswire.com - February 29 at 4:05 PM
msn.com logoPTC Therapeutics Q4 2023 Earnings Preview
msn.com - February 28 at 6:25 PM
marketbeat.com logoPTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Purchased by Charles Schwab Investment Management Inc.
marketbeat.com - February 28 at 4:18 AM
investing.com logoPTC Therapeutics Inc (PTCT)
investing.com - February 28 at 1:24 AM
prnewswire.com logoPTC Therapeutics to Participate at Upcoming Investor Conferences
prnewswire.com - February 27 at 5:20 PM
marketbeat.com logoPTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Sold by Fmr LLC
marketbeat.com - February 24 at 6:02 AM
marketbeat.com logoRathbones Group PLC Makes New $532,000 Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT)
marketbeat.com - February 23 at 7:24 AM
finance.yahoo.com logoPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - February 22 at 8:17 PM
marketbeat.com logoCitigroup Inc. Purchases 116,800 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)
marketbeat.com - February 20 at 5:59 AM
finance.yahoo.com logoPTCT Jun 2024 10.000 put
finance.yahoo.com - February 18 at 10:35 AM
finance.yahoo.com logoPTCT Mar 2024 19.000 put
finance.yahoo.com - February 18 at 10:35 AM
finance.yahoo.com logoPTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 15 at 8:23 AM
prnewswire.com logoPTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
prnewswire.com - February 15 at 8:00 AM
Get PTC Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTCT and its competitors with MarketBeat's FREE daily newsletter.

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

PTCT Media Mentions By Week

PTCT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PTCT
News Sentiment

0.15

0.40

Average
Medical
News Sentiment

PTCT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PTCT Articles
This Week

4

4

PTCT Articles
Average Week

Get PTC Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTCT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PTCT) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners